by jlohrconsulting | Aug 26, 2025 | Uncategorized
Ann Intern Med. 2025 Aug 26. doi: 10.7326/ANNALS-24-03819. Online ahead of print. ABSTRACT BACKGROUND: Rapid changes in the legalized cannabis market have led to the predominance of high-concentration delta-9-tetrahydrocannabinol (THC) cannabis products. PURPOSE: To...
by jlohrconsulting | Aug 26, 2025 | Uncategorized
Schizophr Bull. 2025 Aug 25:sbaf134. doi: 10.1093/schbul/sbaf134. Online ahead of print. ABSTRACT BACKGROUND AND HYPOTHESIS: Digital therapeutics (DTs; health software to treat/alleviate a disease/condition) may provide accessible evidence-based care to people with...
by jlohrconsulting | Aug 26, 2025 | Uncategorized
J Forensic Leg Med. 2025 Aug 21;115:102957. doi: 10.1016/j.jflm.2025.102957. Online ahead of print. ABSTRACT This case study explores the incidental discovery of meningiomas in two adult females who died following suicide by poisoning. A history of generalized...
by jlohrconsulting | Aug 25, 2025 | Uncategorized
Dtsch Arztebl Int. 2025 Oct 17;(Forthcoming):arztebl.m2025.0144. doi: 10.3238/arztebl.m2025.0144. Online ahead of print. ABSTRACT BACKGROUND: Economic resources are vital for the formation of individualized living conditions. By definition, persons suffering from...
by jlohrconsulting | Aug 25, 2025 | Uncategorized
J Youth Adolesc. 2025 Aug 25. doi: 10.1007/s10964-025-02246-0. Online ahead of print. ABSTRACT While existing research has well documented child perfectionism as a risk factor for depressive symptoms, relatively limited studies have delved into the specific influence...
by jlohrconsulting | Aug 25, 2025 | Uncategorized
Psychopharmacology (Berl). 2025 Aug 25. doi: 10.1007/s00213-025-06873-0. Online ahead of print. ABSTRACT INTRODUCTION: Obesity is a global concern leading to significant morbidity and mortality. Naltrexone-Bupropion (NB) is sought to be a favorable medication in obese...
Recent Comments